Company Encyclopedia
View More
name
WEDGE CORPORATION
000534.SZ
Wedge Industrial Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China. The company offers micro-ecological preparations, such as bifidobacterium lactobacillus triple live bacteria tablets under the Golden Bifidobacterium brand; vaginal lactobacillus live capsules under the Dingjunsheng brand; dual-span microecological live bacteria drugs under the Jinshuangqi brand; and vaginal microecological live bacteria drug for use in the treatment of gynecological infections under the Dingjunsheng brand. It also provides probiotic products, health food products, probiotic dietary supplements, probiotic hand creams, and other probiotic health products under the Sanlian Probiotics, Bacteria powder, and Today's Bacteria brands. In addition, the company is involved in the research, development, and manufacture of high-temperature alloy materials and core components, including precision casting blades, high temperature alloy powder discs, high temperature master alloys and their alloy powders, and nickel-based high-temperature master alloys.
1.585 T
000534.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
BiotechnologyIndustry
Industry Ranking37/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE15.97%A
    • Profit Margin18.02%A
    • Gross Margin78.28%A
  • Growth ScoreB
    • Revenue YoY20.40%B
    • Net Profit YoY16.06%B
    • Total Assets YoY21.80%A
    • Net Assets YoY26.33%A
  • Cash ScoreB
    • Cash Flow Margin554.79%C
    • OCF YoY20.40%B
  • Operating ScoreD
    • Turnover0.31D
  • Debt ScoreD
    • Gearing Ratio60.01%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    WEDGE CORPORATION released its performance for the first three quarters, with a net profit attributable to shareholders of 170 million yuan, a year-on-year increase of 22.45%

    According to the Zhitong Finance APP, WEDGE CORPORATION disclosed its third-quarter report for 2025, showing that the company's revenue for the first three quarters reached 941 million yuan, a year-on-year increase of 21%; net profit attributable to shareholders was 170 million yuan, a year-on-year increase of 22.45%; net profit excluding non-recurring items was 157 million yuan, a year-on-year increase of 31.79%; basic earnings per share were 0.3402 yuan

    Zhitong·
    SZ
    000534
    +5.15%
    Zhitong·
    SZ
    000534
    +5.15%

    WEDGE CORPORATION: Net profit in the first half of 2025 increased by 21.84% year-on-year

    WEDGE CORPORATION announced that in the first half of 2025, operating revenue reached 625 million yuan, a year-on-year increase of 24.40%. Net profit was 119 million yuan, a year-on-year increase of 21.84%

    Zhitong·
    SZ
    000534
    +5.15%
    Zhitong·
    SZ
    000534
    +5.15%

    Innovative drug concept stocks saw a partial rebound, with Hanyu Pharmaceutical surging over 10% in the afternoon, Hicin Pharmaceutical, Sun-Novo, and Guangshengtang also rising over 10%. Fuyuan Pharmaceutical and WEDGE CORPORATION hit the daily limit, while Longshen Rongfa, JINGXIN, CSBIO, and Staidson BioPharm followed suit

    Zhitong·
    SZ
    300584
    +0.43%
    SH
    688621
    -1.60%
    SZ
    000534
    +5.15%
    Zhitong·
    SZ
    300584
    +0.43%
    SH
    688621
    -1.60%
    SZ
    000534
    +5.15%

    WEDGE CORPORATION plans to launch a stock incentive plan for 6 million shares

    According to the Zhitong Finance APP, WEDGE CORPORATION disclosed its 2025 equity incentive plan (draft), proposing to grant 6 million restricted shares of the company to the incentive recipients, accounting for 1.19% of the total share capital of the company at the time of the incentive plan announcement. Among them, 5.7225 million shares will be granted in the first grant, with a total of 217 incentive recipients, and the grant price is set at 7.35 yuan/share

    Zhitong·
    SZ
    000534
    +5.15%
    Zhitong·
    SZ
    000534
    +5.15%

    WEDGE CORPORATION and others invest to establish a new technology company

    According to the Qichacha APP, recently, Shenzhen Zhong'an Huasheng Technology Co., Ltd. was established with a registered capital of 1 million yuan. The business scope includes technical services, technical development, technical consulting, technical exchanges, technology transfer, and technology promotion; housing leasing; non-residential real estate leasing; and land use rights leasing. Qichacha's equity penetration shows that the company is jointly held by WEDGE CORPORATION's wholly-owned subsidiary, Shenzhen Wanze Precision Casting Technology Co., Ltd., among others

    Zhitong·
    SZ
    000534
    +5.15%
    Zhitong·
    SZ
    000534
    +5.15%
    © 2025 Longbridge｜Disclaimer